Real-time enrollment status for this hematopoietic and lymphoid cell neoplasm clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 7:51 PM UTC
| NCT Number | NCT05178472 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphoid Cell Neoplasm |
| Phase | NA |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | April 9, 2026 (Apr 9, 2026) |
As of July 19, 2026: Clinical trial NCT05178472 is currently recruiting participants. This na study for hematopoietic and lymphoid cell neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05178472 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05178472 was last updated Apr 9, 2026 (April 9, 2026). HelloStudys verifies this status automatically.